Immune activation |
N (WT EAE, Sarm1 KO EAE) |
Effect size: Sarm1 KO EAE vs. WT EAE [95% confidence interval] |
Mann Whitney p |
IL-4 (pg/ml) |
7, 10 |
3.03 [-4.74, 14.7] |
0.92 |
IL-17 (pg/ml) |
7, 10 |
440 [–259, 1410] |
0.96 |
IFN-γ (pg/ml) |
7, 10 |
5.31x103 [-2.25x103, 1.22x104] |
0.30 |
CD25+Foxp3+ (%CD3+CD4+) |
6, 7 |
-1.14 [-5.86, 3.96] |
0.45 |
CD4+Ki67+ (%CD3+) |
6, 7 |
-0.751 [-2.34, 1.17] |
0.29 |
CNS inflammatory cells (absolute counts) |
N (WT EAE, Sarm1 KO EAE) |
Effect size: Sarm1 KO EAE vs. WT EAE [95% confidence interval] |
Mann Whitney p |
total leukocytes |
6, 7 |
-1.96x105 [-5.26x105, 1.58x105] |
0.29 |
Microglia |
6, 7 |
-2.42x104 [-7.95x104, 2.47x104] |
0.53 |
Macrophage |
6, 7 |
-1.13x105 [-3.24x105, 9.51x104] |
0.37 |
CD11b+Ly6Chi |
6, 7 |
-1.03x105 [-2.39x105, 6x104] |
0.37 |
CD11b+CD11c+ |
6, 7 |
-2.66x104 [-9.88x104, 3.99x104] |
0.73 |
T cells (CD3+) |
6, 7 |
-3.07x104 [-8.96x104, 5.05x104] |
0.29 |
CD3+CD4+ T cells |
6, 7 |
-8.15x103 [-5.9x104, 4.73x104] |
0.95 |
CD3+CD8+ T cells |
6, 7 |
-2.09x104 [-6.62x104, 4.71x102] |
0.37 |
B cells |
6, 7 |
2.31x103 [-2.61x103, 9.32x103] |
0.73 |
Neutrophils |
6, 7 |
-1.45x104 [-4.76x104, 6.11x103] |
0.73 |